digital therapeutics
Dr. Guido Giunti discusses patient involvement and the necessity of being forward-thinking in creating digital therapeutics.
Synthace also announced a new addition to its board of directors.
More hospitals are coming into the fold in the coming months.
Kuldeep Singh Rajput's departure comes just one month after the company laid off 120 employees.
The company let go of 48 workers in the U.S.
At HIMSS23, panelists explained how digital therapeutics must appeal to all healthcare stakeholders – including clinicians, patients, hospitals and payers – to work well in clinical settings.
It now plans to release more hypnosis-based DTx apps for anxiety, sleep, and chronic pain.
Without a transaction, the prescription digital therapeutics company said it may need to reorganize or liquidate.
Earlier this year, the prescription digital therapeutics company said it would put programs related to cognitive health outside of ADHD on hold.
Austin Speier, chief strategy officer at Click Therapeutics, discusses the company's expanded partnership with Boehringer Ingelheim.